Cell Biotech Co., Ltd. (KOSDAQ:049960)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,200
-20 (-0.12%)
At close: Apr 28, 2026
29.39%
Market Cap 110.87B
Revenue (ttm) 53.13B
Net Income (ttm) 10.13B
Shares Out 6.84M
EPS (ttm) 1,479.00
PE Ratio 10.95
Forward PE n/a
Dividend 600.00 (3.70%)
Ex-Dividend Date Dec 29, 2025
Volume 11,273
Average Volume 21,589
Open 16,600
Previous Close 16,220
Day's Range 16,110 - 16,630
52-Week Range 11,350 - 16,710
Beta 0.34
RSI 66.13
Earnings Date May 12, 2026

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1995
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 049960
Full Company Profile

Financial Performance

In 2025, Cell Biotech's revenue was 53.13 billion, an increase of 6.44% compared to the previous year's 49.91 billion. Earnings were 10.13 billion, a decrease of -33.06%.

Financial Statements

News

There is no news available yet.